Radiopharmaceuticals for bone malignancy therapy

HL Atkins, SC Srivastava - Journal of nuclear medicine technology, 1998 - Soc Nuclear Med
Objective: This continuing education article reviews radionuclide bone therapy agents that
are available commercially and introduces agents that are being evaluated for future use …

Recent developments in nuclear medicine in the management of bone metastases: a review and perspective

V Damerla, S Packianathan, PS Boerner… - American journal of …, 2005 - journals.lww.com
Objective: To review recent developments and to examine the role of nuclear medicine-
based radionuclide therapy in the management of bone metastases. Methods: Recent …

[CITATION][C] Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium

GT Krishnamurthy, S Krishnamurthy - Journal of Nuclear Medicine, 2000 - Soc Nuclear Med
Food and Drug Administration for palliation of metastatic bone pain (10— 15). Despite the
use of 32Pin large numbers of patients over many years (Table 1), there is a great …

Radiopharmaceuticals for bone lesions

EKJ Pauwels, MPM Stokkel - The Quarterly Journal of Nuclear …, 2001 - search.proquest.com
Bone scintigraphy continues to be one of the most commonly performed procedures in
nuclear medicine. The radionuclide bone scan remains an excellent modality to detect …

Therapeutic radiopharmaceuticals for bone pain palliation

FF Knapp, A Dash, FF Knapp, A Dash - Radiopharmaceuticals for Therapy, 2016 - Springer
Primary tumors often metastasize when tumor cells migrate via the blood supply or
lymphatics to seed other sites for tumor progression. Particularly in prostate, breast, and lung …

Targeted radionuclide therapy for bone metastases

VJ Lewington - European journal of nuclear medicine, 1993 - Springer
Recent advances in targeted radiotherapy offer a new approach for the management of
metastatic bone pain. This paper will review the scientific basis for radionuclide therapy and …

Radiopharmaceutical therapy for palliation of bone pain from osseous metastases

N Pandit-Taskar, M Batraki… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Bone metastasis occurs as a result of a complex pathophysiologic process between host
and tumor cells leading to cellular invasion, migration adhesion, and stimulation of …

Radionuclide therapy and integrated protocols for bone metastases.

S Chiacchio, S Mazzarri, A Lorenzoni… - The Quarterly Journal …, 2011 - europepmc.org
Bone metastases are responsible for most of the morbidity and mortality associated with
solid malignant tumors, occurring in about 65-70% of the patients with advanced breast or …

[CITATION][C] Future directions for unsealed source radionuclide therapy for bone metastases

VR McCready, JM O'Sullivan - European journal of nuclear medicine and …, 2002 - Springer
Background Unsealed source radiotherapy for skeletal metastases was one of the first
applications of radioisotopes in medicine and dates from more than four decades ago, when …

[CITATION][C] Dosage and response in radiopharmaceutical therapy of painful osseous metastases

EB Silberstein - Journal of Nuclear Medicine, 1996 - Soc Nuclear Med
For correspondence or reprints contact: EdWard B. Silberstein, MD, Eugene L Saenger
Radk@ sotopeLabo ratory, DMsenof NuclearMedidne, Departmentof Ra diology, University …